Fetal lower urinary tract obstruction: What should we tell the prospective parents?
Abnormalities, Multiple
/ diagnostic imaging
Counseling
Female
Fetal Therapies
Humans
Kidney
/ abnormalities
Lung
/ abnormalities
Lung Diseases
/ diagnostic imaging
Male
Oligohydramnios
/ diagnostic imaging
Pregnancy
Prenatal Care
Prenatal Diagnosis
Severity of Illness Index
Ultrasonography, Prenatal
Urethra
/ abnormalities
Urethral Obstruction
/ diagnostic imaging
Urinary Bladder
/ abnormalities
Journal
Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
14
09
2019
revised:
28
01
2020
accepted:
12
02
2020
pubmed:
18
2
2020
medline:
22
6
2021
entrez:
18
2
2020
Statut:
ppublish
Résumé
Fetal lower urinary tract obstruction (LUTO), which often results in marked perinatal morbidity and mortality, is caused by a heterogeneous group of anatomical defects that lead to blockage of the urethra. The classic prenatal presentation of LUTO includes megacystis with hydronephrosis. While mild forms of the disease can be associated with favorable outcomes, more severe disease commonly leads to dysplastic changes in the fetal kidneys, and ultimately oligohydramnios, which can result in secondary pulmonary hypoplasia and renal failure at birth. The aim of this review is to provide practitioners with a general overview of the diagnosis and treatment of LUTO based on disease severity, along with some points to consider when counseling prospective parents of fetuses with this condition.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
661-668Informations de copyright
© 2020 John Wiley & Sons, Ltd.
Références
Malin G, Tonks AM, Morris RK, Gardosi J, Kilby MD. Congenital lower urinary tract obstruction: a population-based epidemiological study. BJOG. 2012;119(12):1455-1464.
Anumba DO, Scott JE, Plant ND, Robson SC. Diagnosis and outcome of fetal lower urinary tract obstruction in the northern region of England. Prenat Diagn. 2005;25(1):7-13.
Devlieger R, Douglas Wilson R, Ruano R. Current controversies in prenatal diagnosis 1: all prenatally detected lower urinary tract obstructions should be shunted. Prenat Diagn. 2018;38(3):155-159.
Ruano R. Fetal surgery for severe lower urinary tract obstruction. Prenat Diagn. 2011;31(7):667-674.
Morris RK, Kilby MD. Long-term renal and neurodevelopmental outcome in infants with LUTO, with and without fetal intervention. Early Hum Dev. 2011;87(9):607-610.
Sananes N, Cruz-Martinez R, Favre R, et al. Two-year outcomes after diagnostic and therapeutic fetal cystoscopy for lower urinary tract obstruction. Prenat Diagn. 2016;36(4):297-303.
Kilby MD, Morris RK. Fetal therapy for the treatment of congenital bladder neck obstruction. Nat Rev Urol. 2014;11(7):412-419.
Ethun CG, Zamora IJ, Roth DR, et al. Outcomes of fetuses with lower urinary tract obstruction treated with vesicoamniotic shunt: a single-institution experience. J Pediatr Surg. 2013;48(5):956-962.
Lewis MA. Demography of renal disease in childhood. Semin Fetal Neonatal Med. 2008;13(3):118-124.
Taghavi K, Sharpe C, Stringer MD. Fetal megacystis: a systematic review. J Pediatr Urol. 2017;13(1):7-15.
McHugo J, Whittle M. Enlarged fetal bladders: aetiology, management and outcome. Prenat Diagn. 2001;21(11):958-963.
Bernardes L, Aksnes G, Saada J, et al. Keyhole sign: how specific is it for the diagnosis of posterior urethral valves? Ultrasound Obstet Gynecol. 2009;34(4):419-423.
Pringle KC, Zuccollo J, Kitagawa H, Koike J, Delahunt B. Renal dysplasia produced by obstructive uropathy in the fetal lamb. Pathology. 2003;35(6):518-521.
Matsell DG, Bennett T, Bocking AD. Characterization of fetal ovine renal dysplasia after mid-gestation ureteral obstruction. Clin Invest Med. 1996;19(6):444-452.
Nicolini U, Fisk NM, Rodeck CH, Beacham J. Fetal urine biochemistry: an index of renal maturation and dysfunction. Br J Obstet Gynaecol. 1992;99(1):46-50.
Ruano R, Safdar A, Au J, et al. Defining and predicting 'intrauterine fetal renal failure' in congenital lower urinary tract obstruction. Pediatr Nephrol. 2016;31(4):605-612.
Ruano R, Sananes N, Wilson C, et al. Fetal lower urinary tract obstruction: proposal for standardized multidisciplinary prenatal management based on disease severity. Ultrasound Obstet Gynecol. 2016;48(4):476-482.
Ruano R, Yoshisaki CT, Salustiano EM, Giron AM, Srougi M, Zugaib M. Early fetal cystoscopy for first-trimester severe megacystis. Ultrasound Obstet Gynecol. 2011;37(6):696-701.
Wu S, Johnson MP. Fetal lower urinary tract obstruction. Clin Perinatol. 2009;36(2):377-390. x.
Kumar Y, Gupta N, Hooda K, et al. Caudal regression syndrome: a case series of a rare congenital anomaly. Pol J Radiol. 2017;82:188-192.
Livingston JC, Elicevik M, Breech L, Crombleholme TM, Pena A, Levitt MA. Persistent cloaca: a 10-year review of prenatal diagnosis. J Ultrasound Med. 2012;31(3):403-407.
Puri P, Shinkai M. Megacystis microcolon intestinal hypoperistalsis syndrome. Semin Pediatr Surg. 2005;14(1):58-63.
Enninga EA, Ruano R. Fetal surgery for lower urinary tract obstruction: the importance of staging prior to intervention. Minerva Pediatr. 2018;70(3):263-269.
Liao AW, Sebire NJ, Geerts L, Cicero S, Nicolaides KH. Megacystis at 10-14 weeks of gestation: chromosomal defects and outcome according to bladder length. Ultrasound Obstet Gynecol. 2003;21(4):338-341.
Berry SM, Lecolier B, Smith RS, et al. Predictive value of fetal serum beta 2-microglobulin for neonatal renal function. Lancet. 1995;345(8960):1277-1278.
Bokenkamp A, Dieterich C, Dressler F, et al. Fetal serum concentrations of cystatin C and beta2-microglobulin as predictors of postnatal kidney function. Am J Obstet Gynecol. 2001;185(2):468-475.
Tassis BM, Trespidi L, Tirelli AS, Pace E, Boschetto C, Nicolini U. Serum beta 2-microglobulin in fetuses with urinary tract anomalies. Am J Obstet Gynecol. 1997;176(1 Pt 1):54-57.
Dommergues M, Muller F, Ngo S, et al. Fetal serum beta2-microglobulin predicts postnatal renal function in bilateral uropathies. Kidney Int. 2000;58(1):312-316.
Spaggiari E, Stirnemann JJ, Benedetti S, et al. Comparison of biochemical analysis of fetal serum and fetal urine in the prediction of postnatal renal outcome in lower urinary tract obstruction. Prenat Diagn. 2018;38(8):585-590.
Ruano R, Dunn T, Braun MC, Angelo JR, Safdar A. Lower urinary tract obstruction: fetal intervention based on prenatal staging. Pediatr Nephrol. 2017;32(10):1871-1878.
O'Hare EM, Jelin AC, Miller JL, et al. Amnioinfusions to treat early onset anhydramnios caused by renal anomalies: background and rationale for the renal anhydramnios fetal therapy trial. Fetal Diagn Ther. 2019;45:365-372.
McNamara HM, Onwude JL, Thornton JG. Megacystis-microcolon-intestinal hypoperistalsis syndrome: a case report supporting autosomal recessive inheritance. Prenat Diagn. 1994;14(2):153-154.
Fontanella F, Duin L, Adama van Scheltema P, et al. Fetal megacystis: prediction of spontaneous resolution and outcome. Ultrasound Obstet Gynecol. 2017;50(4):458-463.
Evans MI, Sacks AJ, Johnson MP, Robichaux AG 3rd, May M, Moghissi KS. Sequential invasive assessment of fetal renal function and the intrauterine treatment of fetal obstructive uropathies. Obstet Gynecol. 1991;77(4):545-550.
Kilby M, Khan K, Morris K, et al. PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction randomised controlled trial. BJOG. 2007;114(7):904-905. e901-904.
Ruano R, Duarte S, Bunduki V, Giron AM, Srougi M, Zugaib M. Fetal cystoscopy for severe lower urinary tract obstruction-initial experience of a single center. Prenat Diagn. 2010;30(1):30-39.
Haeri S, Simon DH, Pillutla K. Serial amnioinfusions for fetal pulmonary palliation in fetuses with renal failure. J Matern Fetal Neonatal Med. 2017;30(2):174-176.
Morris RK, Malin GL, Quinlan-Jones E, et al. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Lancet. 2013;382(9903):1496-1506.
Nassr AA, Shazly SAM, Abdelmagied AM, et al. Effectiveness of vesicoamniotic shunt in fetuses with congenital lower urinary tract obstruction: an updated systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017;49(6):696-703.
Fontanella F, Duin LK, Adama van Scheltema PN, et al. Prenatal diagnosis of LUTO: improving diagnostic accuracy. Ultrasound Obstet Gynecol. 2018;52(6):739-743.
Ruano R, Sananes N, Sangi-Haghpeykar H, et al. Fetal intervention for severe lower urinary tract obstruction: a multicenter case-control study comparing fetal cystoscopy with vesicoamniotic shunting. Ultrasound Obstet Gynecol. 2015;45(4):452-458.
Morris RK, Ruano R, Kilby MD. Effectiveness of fetal cystoscopy as a diagnostic and therapeutic intervention for lower urinary tract obstruction: a systematic review. Ultrasound Obstet Gynecol. 2011;37(6):629-637.
Puttmann KT, White JT, Huang GO, et al. Surgical interventions and anesthesia in the 1st year of life for lower urinary tract obstruction. J Pediatr Surg. 2019;54(4):820-824.
Rosenberg KB, Monk C, Glickstein JS, et al. Referral for fetal echocardiography is associated with increased maternal anxiety. J Psychosom Obstet Gynaecol. 2010;31(2):60-69.
Sklansky M, Tang A, Levy D, et al. Maternal psychological impact of fetal echocardiography. J Am Soc Echocardiogr. 2002;15(2):159-166.
Skari H, Malt UF, Bjornland K, et al. Prenatal diagnosis of congenital malformations and parental psychological distress-a prospective longitudinal cohort study. Prenat Diagn. 2006;26(11):1001-1009.
Brosig CL, Whitstone BN, Frommelt MA, Frisbee SJ, Leuthner SR. Psychological distress in parents of children with severe congenital heart disease: the impact of prenatal versus postnatal diagnosis. J Perinatol. 2007;27(11):687-692.
Skreden M, Skari H, Malt UF, et al. Long-term parental psychological distress among parents of children with a malformation-a prospective longitudinal study. Am J Med Genet A. 2010;152a(9):2193-2202.
Rychik J, Donaghue DD, Levy S, et al. Maternal psychological stress after prenatal diagnosis of congenital heart disease. J Pediatr. 2013;162(2):302-307.e301.
Jensen E, Wood CE, Keller-Wood M. Chronic alterations in ovine maternal corticosteroid levels influence uterine blood flow and placental and fetal growth. Am J Physiol Regul Integr Comp Physiol. 2005;288(1):R54-R61.
de Weerth C, van Hees Y, Buitelaar JK. Prenatal maternal cortisol levels and infant behavior during the first 5 months. Early Hum Dev. 2003;74(2):139-151.
Nathanielsz PW, Berghorn KA, Derks JB, et al. Life before birth: effects of cortisol on future cardiovascular and metabolic function. Acta Paediatr. 2003;92(7):766-772.
Sjostrom K, Valentin L, Thelin T, Marsal K. Maternal anxiety in late pregnancy and fetal hemodynamics. Eur J Obstet Gynecol Reprod Biol. 1997;74(2):149-155.